Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MARX Biotech CoROCO:7731 -3.18%10 Net Margin % is 24.76% as of Dec. 2025, which is 867% above its 10-year median of 2.56. GuruFocus rates ROCO:7731 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, MARX Biotech Co ranks better than 66.92% on this metric.
Net margin is calculated as Net Income divided by its Revenue. MARX Biotech Co's Net Income for the
six
months ended in Dec. 2025 was NT$80.9 Mil. MARX Biotech Co's Revenue for the
six
months ended in Dec. 2025 was NT$326.9 Mil. Therefore, MARX Biotech Co's net margin for the quarter that ended in Dec. 2025 was 24.76%.
The historical rank and industry rank for MARX Biotech Co's Net Margin % or its related term are showing as below:
ROCO:7731'
s Net Margin % Range Over the Past 10 Years
Min: -15.66 Med: 2.56 Max: 14.12
Current: 6.75
ROCO:7731's Net Margin % is ranked better than 66.92% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs ROCO:7731: 6.75
MARX Biotech Co (ROCO:7731) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
MARX Biotech Co Net Margin % Related Terms
MARX Biotech Co Net Margin % Historical Data
* Premium members only.
The historical data trend for MARX Biotech Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MARX Biotech Co Net Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, MARX Biotech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MARX Biotech Co Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where MARX Biotech Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MARX Biotech Co (ROCO:7731) has a Net Margin % of 24.76% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on MARX Biotech Co and its competitors. This is 867% above median its historical median of 2.56. According to the industry distribution chart, MARX Biotech Co ranks #220 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 33.1%.
Is MARX Biotech Co's Net Margin % too high?
MARX Biotech Co's current Net Margin % of 24.76% is 867% above median its 10-year median of 2.56. The Healthcare Providers & Services industry median Net Margin % is 2.90. MARX Biotech Co's value of 24.76% is 753.8% above this industry median. Based on the distribution chart, MARX Biotech Co ranks #220 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MARX Biotech Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #220 out of 665 companies for Net Margin %. This puts MARX Biotech Co in the upper half of its industry. The industry median Net Margin % is 2.90. MARX Biotech Co's value of 24.76% is 753.8% above this benchmark. While the company's 10-year median is 2.56 vs. the industry median of 2.90, MARX Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MARX Biotech Co's current Net Margin % of 24.76% is 753.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current Net Margin % is 24.76%, which is 867% above median its own 10-year median of 2.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Net Margin % of 24.76%. The current Net Margin % is 24.76%, which is 867% above median its 10-year median of 2.56 and 753.8% above the Healthcare Providers & Services industry median of 2.90. MARX Biotech Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Net Margin % is 24.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
10GF Score
Get the complete analysis for ROCO:7731
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7731 has been successfully added to your 
